Myanmar: A Nation of Promise and Public Health Challenges

Myanmar, home to over 55 million people, stands at a pivotal moment in its healthcare journey. With a largely rural population and evolving medical infrastructure, the country faces significant public health challenges — including malaria, tuberculosis, HIV/AIDS, diarrheal diseases, and non-communicable illnesses such as hypertension and diabetes.

Despite progress in recent years, access to quality, affordable medicines remains a central challenge. Public health expenditure is still below global averages, and many essential drugs are imported at high costs. Government efforts, supported by WHO and international partners, continue to focus on Universal Health Coverage (UHC), maternal and child health, immunization drives, and infectious disease control programs.

Government Health Programs and Pharmaceutical Opportunities

Myanmar’s Ministry of Health and Sports (MOHS) has prioritized several key initiatives:

  • National Health Plan (NHP) – expanding primary healthcare access and infrastructure.
  • Essential Drug List (EDL) – promoting availability of WHO-approved, cost-effective medicines.
  • HIV, TB, and Malaria Programs – under Global Fund collaboration.
  • Public Procurement and Tender Systems – inviting global pharmaceutical companies to register and supply affordable generics for hospitals and health departments.

This framework presents strong opportunities for strategic partnerships between reliable pharmaceutical manufacturers and Myanmar’s government and private healthcare sectors.

Taj Pharma India: A Global Commitment to Affordable Healthcare

As one of India’s leading WHO-GMP, PIC’s and ISO-certified pharmaceutical manufacturers, Taj Pharma India is committed to supporting developing nations like Myanmar through ethical manufacturing, transparent registration, and sustainable supply chains.

Located at Sarigam GIDC, Vapi Gujarat, approx 180 KM from Mumbai the Taj Pharma Sarigam Unit stands as a post-pandemic initiative — built with the vision to “help the globe and patients first.” The facility is equipped with state-of-the-art R&D labs, WHO-cGMP-approved manufacturing zones, and advanced quality assurance systems. It produces a broad range of essential and life-saving medicines for international markets.

Taj Pharma’s Mission for Southeast Asia

Under the guidance of Ms. Priyanka Singh, Director Taj Pharma’s Southeast Asia mission emphasizes regional healthcare empowerment, technology-driven production, and affordable drug care.

“At Taj Pharma, we believe healthcare is a human right — not a privilege. Our commitment to Myanmar and neighboring nations is to make high-quality, affordable medicines accessible to all, while supporting local health systems through long-term collaboration and trust.”
— Priyanka Singh, Director, Taj Pharma

Major Medicines and Therapeutic Areas for Myanmar

Taj Pharma proposes a wide range of WHO-prequalified and dossier-ready pharmaceutical products suitable for Myanmar’s Essential Drug List and hospital tenders, including:

Manufacturer of Hydroxychloroquine 200mg Tablets Supplier PAN India
Hydroxychloroquine 200mg Tablets
  • Anti-Infectives: Metronidazole, Ciprofloxacin, Azithromycin, Ceftriaxone Injection, Amoxicillin + Clavulanic Acid.
  • Antimalarials: Mefloquine, Artemether + Lumefantrine, Artesunate Tablets and Injection.
  • Cardiovascular & Diabetes Care: Amlodipine, Atenolol, Losartan, Metformin, Glimepiride.
  • Pain & Fever Management: Paracetamol, Ibuprofen, Diclofenac.
  • Dermatologicals & Topicals: Chlorhexidine Solution, Aqueous Cream, Antifungal and Antibacterial Ointments.
  • Nutraceuticals & Vitamin Supplements: Multivitamin Syrups, Vitamin C Tablets, Oral Rehydration Salts (ORS), and Cod Liver Oil Capsules.

These formulations are designed to meet regional climatic stability, cost-effectiveness, and compliance with Myanmar FDA and ASEAN ACTD dossier requirements.

Business Collaboration and Tender Participation

Taj Pharma actively welcomes Myanmar’s licensed distributors, tender agents, and healthcare organizations to collaborate in the following areas:

  • Government and institutional supply tenders through MOHS and international NGOs.
  • Private market distribution and branded generics under Taj Pharma or private label.
  • Dossier registration and local partnership development for long-term sustainable access.

Through dedicated support, Taj Pharma offers technical documentation (CTD/ACTD format), product stability data, COA, and regulatory compliance assistance for smooth market entry.

Post-Corona Commitment: Healing Beyond Borders

The COVID-19 pandemic underscored the global inequity in medicine access. In response, Taj Pharma expanded its Sarigam operations to triple production capacity, focusing on critical care drugs, injectables, and essential tablets for export.

This initiative aligns with the company’s vision of global health resilience — supporting emerging economies like Myanmar with uninterrupted medicine supply and price-controlled healthcare solutions.

Vision & Mission: South-East Asian Healthcare Empowerment

Taj Pharma’s mission in Southeast Asia is rooted in three pillars:

  1. Accessibility – Delivering WHO-standard medicines at affordable prices.
  2. Affordability – Ensuring cost-effective production through advanced Indian pharma technology.
  3. Accountability – Maintaining ethical transparency, regulatory compliance, and global humanitarian focus.

“Our partnership vision is simple — healthy people build strong nations. Taj Pharma is proud to extend India’s pharmaceutical strength to support Myanmar’s national health goals and regional prosperity.”
— Priyanka Singh

About Taj Pharma India Ltd.

Taj Pharma India Ltd. is a leading manufacturer and exporter of pharmaceutical formulations with global operations in over 40 countries. The company holds WHO-GMP, ISO, GLP, EU-GMP (In Pipe Line), and PIC/S certifications, with a strong presence across Asia, Africa, CIS, and Latin America.

For collaboration and registration partnerships in Myanmar:
📧 Sales@tajpharmaindia.com / Info@tajpharma.com

What’s App Support: +91-7861865490 / +91 74 0000 9975 / 76

General Line: +91 84484 44095 / Land Line: +91 – 22 – 2637 4592 / 2637 4593
🌐 www.tajpharma.in | www.tajgenerics.com | www.tajpharma.com